Products

Anti-IL13RA2 scFv (mu07) (TAB-0154CL-S(P))

The anti-IL-13-Ra2 antibody-drug conjugates can exert a cytotoxic effect on IL-13-Ra2 expressing tumour cells and without undesirable effects of non-IL-13-Ra2 expressing cell, and thus can be used for the treatment of cancer like pancreatic cancer, breast cancer, ovarian cancer and malignant gliomas.      

Specifications
Immunogen
Human IL-13Ra2
Host
Mouse
Specificity
Human
Clone
mu07
Related Disease
Pancreatic cancer, breast cancer, ovarian cancer, malignant gliomas
Target
Alternative Names
IL13RA2; interleukin 13 receptor, alpha 2; CT19; IL-13R; IL13BP; CD213A2; interleukin-13 receptor subunit alpha-2; IL-13RA2
Entrez Gene ID
3598
UniProt ID
Q14627

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved